Hybrid immunity augments cross-variant protection against COVID-19 among immunocompromised individuals.

MLA

Quek, Amy May Lin, et al. “Hybrid Immunity Augments Cross-Variant Protection against COVID-19 among Immunocompromised Individuals.” The Journal of Infection, vol. 89, no. 4, Oct. 2024, p. 106238. EBSCOhost, https://doi.org/10.1016/j.jinf.2024.106238.

APA

Quek, A. M. L., Wang, S., Teng, O., Shunmuganathan, B., Er, B. G. C., Mahmud, N. F. B., Ng, I. X. Q., Gupta, R., Tan, I. S. L., Tan, N. Y., Qian, X., Purushotorman, K., Teoh, H. L., Ng, K. W. P., Goh, Y., Soon, D. T. L., Tay, S. H., Teng, G. G., Ma, M., … Seet, R. C. S. (2024). Hybrid immunity augments cross-variant protection against COVID-19 among immunocompromised individuals. The Journal of Infection, 89(4), 106238. https://doi.org/10.1016/j.jinf.2024.106238

Chicago

Quek, Amy May Lin, Suqing Wang, Ooiean Teng, Bhuvaneshwari Shunmuganathan, Bernadette Guek Cheng Er, Nor Fa’izah Binte Mahmud, Isabel Xue Qi Ng, et al. 2024. “Hybrid Immunity Augments Cross-Variant Protection against COVID-19 among Immunocompromised Individuals.” The Journal of Infection 89 (4): 106238. doi:10.1016/j.jinf.2024.106238.